Biotech

All Articles

Despite combined market, an equity capital rebirth could be coming in Europe: PitchBook

.While the biotech investment performance in Europe has decreased rather complying with a COVID-19 f...

8 months after a $213M fundraise, genetics publisher Tome creates cuts

.After increasing $213 million in 2023-- one of the year's biggest private biotech shots-- Tome Bios...

BioMarin develops director crew along with biotech veterinarians-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial leadership hirings, firings and r...

Biopharma Q2 VC reached highest degree since '22, while M&ampA slowed

.Financial backing backing into biopharma rose to $9.2 billion across 215 handle the 2nd fourth of t...

Bicara, Zenas look for IPOs to push late-phase resources toward market

.Bicara Rehabs and also Zenas Biopharma have actually provided fresh inspiration to the IPO market w...

Genentech to finalize cancer cells immunology analysis team

.Genentech will certainly shut its cancer immunology analysis team, as well as device head and promi...

Kezar falls sound growth yet to verify its well worth in stage 1 test

.Kezar Lifestyle Sciences is actually losing its dim phase 1 strong growth medicine as the biotech g...

Acelyrin goes down izokibep, drops 3rd of personnel

.In spite of izokibep sustaining its own newfound winning streak in the clinic, Acelyrin is actually...

Rivus' period 2 obesity-related cardiac arrest trial strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid stops preclinical job, IV plan after soticlestat fail

.Ovid Rehab already disclosed final month that it was actually trimming back its own headcount as th...